Tumor Stage | Training Set | Â | Â | Validation Set | Â | Â |
---|
 | Node positive | Node negative | Total | Node positive | Node negative | Total |
---|
Normal controls | Â | 3 | 3 | Â | 2 | 2 |
pTa | 0 | 3 | 3 | 0 | 7 | 7 |
pT1 | 2 | 6 | 8 | 1 | 4 | 5 |
pT2 | 0 | 4 | 4 | 0 | 4 | 4 |
pT3 | 7 | 5 | 12 | 7 | 3 | 10 |
pT4 | 2 | 2 | 4 | 2 | 1 | 3 |
Grand total
| 11 | 23 |
34
| 10 | 21 |
31
|
- The total cohort of 65 subjects included five normal controls that were classified as node negative. An approximately equal distribution of the subjects was attempted between both sets in all tumor stages and nodal classes to eliminate bias. Tumor and nodal stages was determined according to the American Joint Committee on Cancer recommended TNM system for urinary bladder cancer (2002).